Sikander Ailawadhi¹, Swetha Challagulla^2*, Dominic Pilon^3*, Yan Meng, PhD^4*, Mei Xue^2*, Yuxi Wang^3* and Keri Yang^2*

¹Mayo Clinic, Jacksonville, FL
²BeiGene, San Mateo, CA
³Analysis Group, Inc., Montreal, QC, Canada
⁴Analysis Group, Ltd, London, United Kingdom

Matthew Meranda¹, Madison Drallmeier, DO^2*, Sisira Kavuri, MD^2*, Jamie Abad, MD^2*, Aayush Mittal, MD^2*, Rida Farook^3*, Muniza Hossain, MS^2*, Courtney Rose, MS^2*, Carl Wilson, MS^2*, Muhammad Shahid, DO^4*, Philip Kuriakose, MD⁵ and Ahmad H. Mattour, MD⁴

¹Henry Ford Health, Bloomfield Hills, MI
²Henry Ford Health, Detroit, MI
³Wayne State University School of Medicine, Detroit, MI
⁴Hematology and Oncology; Henry Ford Cancer Institute, Henry Ford Health, Detroit, MI
⁵Hematology and Oncology, Henry Ford Health, Detroit, MI

Marsali Maclean^1*, Niamh Waters, MBBS^2*, Charmaine Smith^3*, Darcy Vickers^1*, Dawn Swan, MRCP, FRCPath^1,4*, Arina Martynchyk^1*, Denise Lee, MBBS^2*, Geoffrey Chong^5* and Eliza A. Hawkes, MD^6,7,8

¹Department of Clinical Haematology, Austin Health, Melbourne, VIC, Australia
²Austin Hospital, Melbourne, VIC, Australia
³Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Heidelberg, VIC, Australia
⁴Hematology, Beaumont Hospital, Waterford, Ireland
⁵Olivia Newton-John Cancer Centre, Heidelberg, VIC, Australia
⁶School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
⁷Austin Health, Olivia Newton-John Cancer Research & Wellness Centre, Melbourne, Australia
⁸Austin Health, Olivia Newton John Cancer Research Institute, Heidelberg, VIC, Australia

Ryan Jacobs¹, Luke Fletcher^2,3, Andrew Rettew^4*, Sophia S Li^5*, Katherine Eakle^5*, Mina Shahkarami^5*, Rongrong Wang^5*, Tu My To^5*, Susan D Mathias^6*, Isabella Manigault^7* and John M. Burke^2,8

¹Levine Cancer Institute, Charlotte, NC
²Sarah Cannon Research Institute, Nashville, TN
³Willamette Valley Cancer Institute and Research Center, Eugene, OR
⁴McGlinn Cancer Institute, Tower Health, West Reading, PA
⁵Genentech, Inc., South San Francisco, CA
⁶Health Outcomes Solutions, Palm Beach Gardens, FL
⁷Aptitude Health, Atlanta, GA
⁸Rocky Mountain Cancer Centers, Aurora, CO

Monia Marchetti, MD, PhD^1*, Paolo Corradini, MD², Luca Arcaini, MD^3*, Stefania Bramanti^4*, Alice Di Rocco, MD^5*, Marco Ladetto, MD⁶, Stefano Luminari⁷, Luigi Rigacci^8* and Pier Luigi Zinzani, MD, PhD⁹

¹Hematology & Transplant Unit, University Hospital SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
²University of Milan. Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
³Department of Molecular Medicine, University of Pavia and Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁴Bone Marrow Transplantation and Cell Therapy Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy
⁵Hematology, Departement of Traslational and Precision Medicine, Sapienza University of Rome, Rome, Italy
⁶Department of Translational Medicine, Università del Piemonte Orientale ed SCDU Ematologia AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Piedmont, Italy
⁷Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
⁸Fondazione Policlinico Campus Bio-Medico e Università Campus Bio-Medico, Rome, Italy
⁹Department of Medical and Surgical Sciences, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy

Bolivar Diaz Jordan, MD^1*, Marta Torcal Baz^1*, Claudia Corona Lopez^1*, Francisco Javier Gomez Romero^2*, Ana Rosa Lopez Quiñones Pimentel^3*, Maria Isabel Goyanes Martin^3*, Rosario Melero Cañadas^1*, Raquel Jimenez Megia^1*, Almudena Valverde Templado^1*, Ana Belen Friginal Ruiz^3*, Claudia Maria Rodriguez Gomez^1*, Teresa Cañizares Fernandez^1*, Gema Garrandes Gallego^1*, Maria Eugenia Carrillo Coca^1* and Martin A. Cabero-Becerra, MD, PhD⁴

¹Valdepeñas General Hospital, Castilla-La Mancha Health Service, Valdepeñas, Spain
²Ciudad Real University General Hospital, Castilla-La Mancha Health Service, Ciudad Real, Spain
³Hospital Virgen de Altagracia, Castilla-La Mancha Health Service, Manzanares, Spain
⁴La Mancha Centro Hospital, Castilla-La Mancha Health Service, Alcazar De San Juan, Ciudad Real, ESP

Sikander Ailawadhi¹, Timothy J. Inocencio^2*, Zheng-Yi Zhou^3*, Michael K. Xu^3*, Jack Eales^3*, Michelle Little², Peter Quon^2* and Qiufei Ma^2*

¹Division of Hematology, Mayo Clinic, Jacksonville, FL
²Regeneron Pharmaceuticals, Inc., Tarrytown, NY
³Analysis Group, Inc., Boston, MA

Tiana Kordbacheh, MBBS, PhD, BSc¹, Anca Prica, MD, MSc^1,2*, Kelvin KW Chan, MD, PhD^3*, Mahmood Aminilari, PhD^4*, Zharmaine Ante^5*, Ning Liu, PhD^6*, Inna Y Gong, MD, PhD^1,2, Sita D. Bhella, MD^1,7, Michael Crump, MD^1,2*, Abi Vijenthira, MD, SM^2,8, John Kuruvilla, MD, FRCPC^2,9, Robert Kridel, PhD^1,2, Christine I Chen, MHPE, MD^2,10, Vishal Kukreti, MD, MSc^2,8, Chloe Yang, MD^2,11*, Nauman Malik^4,12*, David Hodgson, MD^4,12* and Danielle Rodin, MD, MPH^4,12*

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³Division of Hematology and Oncology, Department of Medicine, University of Toronto, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
⁴Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada
⁵Research & Analysis, ICES, Toronto, ON, Canada
⁶ICES, Toronto, ON, Canada
⁷University of Toronto, Toronto, ON, Canada
⁸Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁹Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁰Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
¹¹Princess Margaret Cancer Centre, Toronto, ON, Canada
¹²Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada

Victoria A Gill, BA¹, Christina Raker, ScD^2*, Adam J. Olszewski, MD³, John L. Reagan, MD⁴ and Ari Pelcovits, MD⁴

¹Brown University, Providence, RI
²Biostatistics, Epidemiology, and Research Design, Rhode Island Hospital, Providence, RI
³Brown Univeristy, Providence, RI
⁴Brown University Health Cancer Institute, Brown University Health, Providence, RI

Radhika Bansal, MBBS^1*, Andre Corraes, MD^2*, Monica Shaw^3*, Lucy Holmes, ANP^4*, Allison Kosobud, PA-C^4*, Kelsey L Haugen^5*, Arushi Khurana, MBBS², Paul J. Hampel, MD², Urshila Durani, MD, MPH², Suzanne R Hayman, MD², Yucai Wang, MD, PhD², Moritz Binder, MD², Jonas Paludo, MD², Saad S. Kenderian, MD², N. Nora Bennani, MD², Patrick B. Johnston, MD, PhD^5*, Stephen M. Ansell, MD, PhD² and Yi Lin, MD, PhD²

¹Internal Medicine, Zucker School of Medicine at Hofstra/Northwell at Lenox Hill, New York, NY
²Division of Hematology, Mayo Clinic, Rochester, MN
³Deptt of hematology, Mayo CliniC, Rochester, MN
⁴Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
⁵Mayo Clinic, Rochester, MN

Alison Carulli, PharmD^1*, Hayden Elliott, PA-C^1*, Brendan Mangan, PharmD^1*, James Whittenburg, PA-C^1*, Elise A. Chong, MD², Sunita D. Nasta, MD³, Jakub Svoboda, MD², Stefan K. Barta, MD², David L. Porter, MD², Jordan S. Carter, MD², Michael Roderick Cook, MD², Nasheed Hossain, MD^2*, Saar Gill, MD, PhD², Alfred L. Garfall, MD⁴, Christopher Catania^2*, Colleen R. Kucharczuk, DNP^1*, Stephen J. Schuster, MD², Noelle Frey, MD, MS⁵ and Daniel J. Landsburg, MD²

¹Hospital of the University of Pennsylvania, Philadelphia, PA
²School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
³Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁴Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
⁵University of Pennsylvania, Philadelphia, PA

Swetha Kambhampati Thiruvengadam, MD^1,2, Jordan S Goldstein, MD, MSc³, Seth Buller, BS^4*, Mark Roschewski, MD⁵, Ash A. Alizadeh, MD, PhD⁶ and Nikhil Thiruvengadam^7*

¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
²City of Hope National Medical Center, Yorba Linda, CA
³Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Palo Alto, CA
⁴Loma Linda University School of Medicine, Loma Linda, CA, CA
⁵National Cancer Institute, Bethesda, MD
⁶Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁷Gastroenterology, Loma Linda University, Loma Linda, CA

Abeer Yaseen, MD^1*, Mohammad Ma'koseh, MD^2*, Albatol Alamoush^2*, Anas Zayed, MD^3*, Mona Ribie, MD^2*, Marah Alzubi^4*, Jawad Alrawabdeh^4*, Rozan Alfar^2*, Waleed Kamel Da'Na, MD^2*, Salwa Shihadeh Saadeh, MBBS, MRCP^2*, Yazan Talab, MD^2*, Husam Abu Jazar, MD^2*, Samer Al-Hadidi, MD^5*, Sameer Yaser, MD^2* and Zaid Abdel Rahman, MD⁶

¹KIng Hussein Cancer Center, Amman, Jordan
²King Hussein Cancer Center, Amman, Jordan
³King Hussein Cancer Center, Jubeiha, Jordan
⁴University of Jordan, Amman, Jordan
⁵University of Arkansas for Medical Sciences, Little Rock, AR
⁶Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan

Tamer Othman, MD¹, John H. Baird, MD², Yan Wang^3*, Stacy Pak^4*, Ibrahim Aldoss, MD², Ji-Lian Cai^4*, Alexey Danilov, MD, PhD⁵, Tycel J. Phillips, MD⁶, Vaibhav Agrawal, M.D.², Karamjeet S Sandhu, MD², Matthew Mei, MD⁷, Paul B. Koller, MD², Joycelynne Michelle Palmer, PhD^3*, Stephen J. Forman, MD, FACP⁸, Lihua E. Budde, MD, PhD⁹ and Ahmed Aribi, MD^10*

¹Hematology/HCT, City of Hope, San Lorenzo, CA
²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³City of Hope, Duarte, CA
⁴City of Hope, Daurte, CA
⁵City of Hope Comprehensive Cancer Center, La Canada Flintridge, CA
⁶City of Hope, Pasadena, CA
⁷City of Hope Cancer Center, Duarte, CA
⁸Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
⁹Department of Hematology and HCT, City of Hope, Duarte, CA
¹⁰Hematology/HCT, City of Hope National Medical Center, Duarte, CA

Nadia Syed, DO^1*, Stacie Dusetzina, PhD^2*, Tatsuki Koyama, PhD^3*, Emma Schremp, MS^1*, Meredith Smalls, MPH^4* and Debra L. Friedman, MD, MS⁵

¹Vanderbilt University Medical Center, Nashville, TN
²Vanderbilt University, Nashville, TN
³Vanderbilt University School of Medicine, Nashville, TN
⁴Meharry-Vanderbilt Alliance, Nashville
⁵Vanderbilt-Ingram Cancer Center, Nashville, TN

Bridget Doherty, MPH^1*, Agnes Benedict, MSc, MA^2*, Silas Martin, MSc^3*, Gabor Szabo, MSc^4* and Kinga Marczell, PhD^4*

¹Johnson & Johnson Innovative Medicine, Swarthmore, PA
²Evidera, Vienna, Austria
³Johnson & Johnson Innovative Medicine, Titusville, NJ
⁴Evidera, Budapest, Hungary

Ghulam Rehman Mohyuddin, MD¹, Rajshekhar Chakraborty, MD², Katherine Berger^3*, Ryan Winborg^4*, Mason S. Barnes, B.S.^5*, Jorge Arturo Hurtado Martinez, MD^5*, Jay R. Hydren, PhD⁵, Douglas W Sborov, MD¹, Amandeep Godara¹, Brian McClune, DO⁶, Christopher Booth^7* and Edward R Scheffer Cliff, MBBS, MPH⁸

¹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
³University of Harford, Connecticut
⁴Brigham Young University, Provo
⁵HealthTree Foundation, Lehi, UT
⁶Huntsman Cancer Institute, University of Utah, Division of Hematology and Hematologic Malignancies, Salt Lake City, UT
⁷Queens University, Kingston, ON, Canada
⁸Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

Xin Shelley Wang, MD, MPH¹, Samer A. Srour, MD², Sattva S. Neelapu, MD³, Shu-En Shen, MS^1*, Laila Noor, PhD^1*, Sairah Ahmed, MD³ and Elizabeth J. Shpall, MD²

¹Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Izel Okcu^1*, Arushi Khurana, MBBS¹, Urshila Durani, MD, MPH¹, Robert J. Levy, MD^2*, Muhamad Alhaj Moustafa, M.D., M.S.³, Allison C. Rosenthal, DO⁴, Robert Delaune, MD^5*, Daniel P. Larson, MD^6*, Thomas E. Witzig, MD⁷, Matthew T. Howard, MD^6*, Gregory A. Wiseman, MD^6*, Madiha Iqbal, MD⁸, Nneka I. Comfere^6*, Namrata Shah, MD^9*, Lawrence Breitkreutz, MD^10*, Mike S. Bold, MD^11*, Yucai Wang, MD, PhD¹, Brendan W. Lunn, MD^12*, Scott C. Lester, MD^13*, William G. Breen, MD^13*, Bradford S Hoppe, MD, MPH^14*, Caroline R. Hill, RN^6*, Valerie M. Kimball, RN, OCN^6*, Adrienne N. Nedved, PharmD^15*, Ruth A. Lentz, RN^6*, Rebecca L. King, MD¹⁶ and Thomas M. Habermann, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Conn Oncology Group, Middletown, CT
³Division of Hematology, Mayo Clinic, Jacksonville, FL
⁴Division of Hematology/Oncology Mayo Clinic, Phoenix, AZ
⁵Maplewood Cancer Center, Saint Paul, MN
⁶Mayo Clinic, Rochester, MN
⁷Division of Hematology, Mayo Clinic, Stabile 628, Rochester, MN
⁸Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁹Hancock Health, Greenfield, IN
¹⁰Baton Rouge General Medical Center, Baton Rouge, LA
¹¹Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, MN
¹²Department of Radiology, Mayo Clinic, Rochester, MN
¹³Department of Radiation Oncology, Mayo Clinic, Rochester, MN
¹⁴Mayo Clinic, Jacksonville, FL
¹⁵Department of Pharmacy, Mayo Clinic, Rochester, MN
¹⁶Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Bronagh McGoldrick^1*, Evelyn Evans^2*, James Williams^2*, Gemma Martin^2*, Bronagh McGoldrick^3*, Mary Warren^2*, David Davies^2*, Charis Hillberg^2*, Kelly Fletcher^2*, Joely Ford^2*, Abigail Downing^2*, James Murray, MBBChir, PhD^2*, Ceri Jones, MD, PhD, FRCPath^4*, Emma Kempshall^2*, Wendy A Ingram, MD, MBBS, PhD, FRCPath, MRCP⁵, Laura Ricketts^2* and Keith Wilson, FRCP, FRCPath^6*

¹Cardiff and Vale University Health Board, Cardiff, WAL, GBR
²Cardiff and Vale University Health Board, Cardiff, United Kingdom
³Cardiff and Vale University Health Board, Cardiff, WAL, United Kingdom
⁴University Hospitals Wales, Cardiff, United Kingdom
⁵University Hospital Wales, Cardiff, GBR
⁶University Hospital of Wales, Cardiff, GBR

Danielle Ross, DO^1*, Stephen Caucci^2*, Hajir Alobaidi^3*, Christiane A. Houde, BS^4*, Katrina Reid^5*, Nikhil Vojjala, MD⁶, Jeffrey A. Zonder, MD ³ and Craig Emmitt Cole, MD⁷

¹Department of Internal Medicine, McLaren Greater Lansing/ Michigan State University, Lansing, MI, Lansing, MI
²Department of Internal Medicine, McLaren Greater Lansing/ Michigan State University, Lansing, MI
³Karmanos Cancer Institute, Detroit, MI
⁴Barbara Ann Karmanos Cancer Institute / Wayne State University School of Medicine, Detroit, MI
⁵Michigan State University College of Human Medicine, East Lansing, MI
⁶Internal Medicine, Trinity Health Oakland/Wayne State University School of Medicine, Pontiac, MI
⁷Karmanos Cancer Institute/Wayne State University, Detroit, MI

Romain Winer, PharmD^1*, Marguerite Vignon, MD^2*, Mathis Collier, PhD^3*, Guillemette Fouquet, MD, PhD^4*, Olivier Hermine, MD, PhD⁵, Clarisse Cazelles, MD^5*, Laurent Frenzel, MD, PhD^5*, Sylvain Choquet, MD^6*, Laurent Garderet^7*, Karim Belhadj Merzoug, MD, PhD^8*, Thorsten Braun, MD, PhD^9*, Didier Bouscary, MD, PhD^2*, Marie-Laure Brandely-Piat, PharmD^2*, Clement Leclaire, MD, PhD^1*, Maya Gutierrez, MD, PhD^1*, Frederique Moufle, MD^1*, Cecile Chauvin, PharmD^1*, Arnaud Soulignac, PharmD^1*, Arsene Zogo, PharmD^1*, Philippe Moreau, MD, PhD^10* and Jeremie Zerbit, PharmD, PhD^1*

¹Hospital at Home, Greater Paris University Hospitals (AP-HP), Paris, France
²Hematology, Cochin Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
³Clinical Research Unit, Cochin Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁴Hematology Department, Hospital Sud Francilien, Corbeil-Essonnes, France
⁵Hematology, Necker Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁶Pitie-Salpetriere Hospital, Paris, France
⁷Hematology, Pitie-Salpetriere Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁸Unit of Lymphoid Hemopathies, Henri Mondor Hospital, Greater Paris University Hospitals (AP-HP), Creteil, France
⁹Hematology, Hospital Avicenne, Greater Paris University Hospitals (AP-HP), Bobigny, France
¹⁰Hematology, University Hospital of Nantes, Nantes, France

Darryl Chang, MD¹, Myra Robinson^2*, Rupali Bose, MS, MBA^2*, Hamid Ehsan, MD, MBBS, MS¹, Arunkumar Krishnan, MD, MS^3*, Shanice Borden^1*, Peter M. Voorhees, MD⁴, Barry Paul, MD, MS⁵, Manisha Bhutani, MD⁶, Cindy Varga, MD, BSc⁴, Christopher Ferreri⁴ and Shebli Atrash, MD, MS⁴

¹Levine Cancer Institute, Atrium Health, Charlotte, NC
²Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
³Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁴Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁵Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁶Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC

Anas Zayad^1,2*, Nausheen Ahmed, MD^3,4*, Zahra Mahmoudjafari, PharmD^3,4*, Barry Skikne, MD^3,4*, Tara L. Lin, MD⁵, Muhammad Umair Mushtaq^3,4, Joseph P. McGuirk, DO^3,6, Al-Ola Abdallah, MD^3,4, Omar Alkharabsheh, MD^3,7* and Shebli Atrash, MD^3,8

¹Hamad Medical Corporation, Doha, CA, Qatar
²US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS
³US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁴Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁵Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS
⁶University of Kansas Medical Center, Westwood, KS
⁷University of South Alabama, Mobile, AL
⁸Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC

Rifeta Kajdic Hodzic, CHPM^1*, Amitkumar N. Mehta, MD², Jean L. Koff, MD, MSc³, Elizabeth Budde, MD, PhD⁴, Srinivas Devarakonda, MD⁵, Donald C Moore, PharmD, BCPS, BCOP, DPLA, FCCP^6*, Joshua Brody^7*, Bradley Wuthrich, PharmD^8*, Robert Mancini, PharmD, BCOP, FHOPA^9*, Cassie Martin, MMS, PA-C^10*, Christina Mangir, MS^11*, Allison Harvey, MPH, CHES^12*, Elana Plotkin, CMP-HC^1*, Molly Kisiel, MSN, FNP-BC^1*, Ashley Lile, MPH, LSSGB^1* and Nicole A Colwell, MD^1*

¹Association of Cancer Care Centers, Rockville, MD
²O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
³Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁴Department of Hematology and HCT, City of Hope, Duarte, CA
⁵Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁶Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁷Icahn School of Medicine at Mount Sinai, New York, NY
⁸Cowell Family Cancer Center, Traverse City, MI
⁹St. Luke's Cancer Institute, Boise, ID
¹⁰Penn Medicine Lancaster General Health, Lancaster, PA
¹¹Rhizome, LLC, Washington, DC, DC
¹²Rhizome, LLC, Washington, DC